-+ 0.00%
-+ 0.00%
-+ 0.00%

Kymera Therapeutics director Elena Ridloff disposes of 3,000 shares for $261,000

PUBT·05/11/2026 20:59:39
Listen to the news
Kymera Therapeutics director Elena Ridloff disposes of 3,000 shares for $261,000
  • Kymera Therapeutics director Elena Ridloff sold 3,000 common shares on May 11, 2026 at USD 87, cutting direct holdings to 0 shares.
  • Ridloff exercised stock options for 3,000 shares at USD 31.2 in a same-day transaction.
  • Stock options beneficially owned fell to 13,000 following the exercise.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-217041), on May 11, 2026, and is solely responsible for the information contained therein.